Skip to content

PROXYPHARMA LLB

Active
Private limited companyfounded 2008active for 18 yearsRue de Sclef, Meux 47, 5081 La Bruyère, BelgiumKBO/BCE: BE 0898.752.807
Summary

PROXYPHARMA LLB has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €532,755 and a net result of €35,296. Equity remains stable across the filed financial years (±2% per year). Its solvency ranks better than 86% of 12,626 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
8th largest company by equity in La Bruyère, Wholesale and retail trade sector1 site
Size
€707,554total assets 2025
Staff
2.1 FTE
Equity
€532,755
Profit
€35,296
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Board
4 members
Accounts 7 days early1 of 3 deeds read
Why 95lowers riskFounded in 2008Equity €532,755 (75.3% of total assets)Liquidity: current ratio 4.14, cash €86,322Figures for financial year 2025 (filed 24-07-2026)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 62% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 100+3
equity 75.3% of total assets
Liquidity 57-9
short-term debt 23.5% · cash 12.2%
Profitability 75+1
return on assets 5.0%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,226 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.2%▲ +0.1 percentage points vs 05-2025 07-2025: 0.3%▲ +0.1 percentage points vs 06-2025highest value 08-2025: < 0.1%▼ -0.3 percentage points vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: 0.1%▲ +0.1 percentage points vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €50,000 on 30-day terms is acceptable
Liquidity ample (current ratio 4.14, compared with 3.73 in 2024, above the usual 1.5; short-term debt: 23.5% and cash: 12.2% of total assets), and 24.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 92% on solvency, 63% on liquidity, 61% on profitability and 32% on growth.

The bankruptcy probability was computed on 22-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Founded in 2008
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Equity €532,755 (75.3% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 4.14, cash €86,322
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 24-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
7 days early
2024
15 days early
2023
47 days early
2022
52 days early
2021
41 days early
2020
44 days early
2019
46 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 36 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
23-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · full…
  3. Annual accounts filedfinancial year 2023 · full…

Financials · financial year 2025, abbreviated format

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€35,296▲ 1.6%
2024 · €34,736
Working capital
€522,259▼ 4.8%
2024 · €548,671
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result has fallen three years in a row; 2025 is 2% below 2024 and is the lowest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€43,161 2025 Net result€35,296 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€1,218-€17,529▲ 1,339%-€2,898€64,882€99,477▲ 53.3%€87,568▼ 12.0%€43,960▼ 49.8%€43,161▼ 1.8%
Net result-€6,940-€5,192-€19,842below the sector's middle half€41,643within the sector's middle half€79,212within the sector's middle half▲ 90.2%€71,437within the sector's middle half▼ 9.8%€34,736within the sector's middle half▼ 51.4%€35,296within the sector's middle half▲ 1.6%
Equity€495,083-€500,274▲ 1.0%€480,432within the sector's middle half▼ 4.0%€522,075within the sector's middle half▲ 8.7%€551,287within the sector's middle half▲ 5.6%€572,723within the sector's middle half▲ 3.9%€557,459within the sector's middle half▼ 2.7%€532,755within the sector's middle half▼ 4.4%
Total assets€656,170-€636,403▼ 3.0%€627,756within the sector's middle half▼ 1.4%€654,302within the sector's middle half▲ 4.2%€752,829within the sector's middle half▲ 15.1%€761,631within the sector's middle half▲ 1.2%€776,847within the sector's middle half▲ 2.0%€707,554within the sector's middle half▼ 8.9%
Debt€161,087-€136,129▼ 15.5%€147,324▲ 8.2%€132,227▼ 10.2%€201,542▲ 52.4%€188,907▼ 6.3%€219,388▲ 16.1%€174,799▼ 20.3%
Working capital€473,317-€501,174▲ 5.9%€488,792above the sector's middle half▼ 2.5%€539,939above the sector's middle half▲ 10.5%€537,476above the sector's middle half▼ 0.5%€568,255above the sector's middle half▲ 5.7%€548,671above the sector's middle half▼ 3.4%€522,259above the sector's middle half▼ 4.8%
Solvency75.5%-78.6%▲ 3.2pp76.5%above the sector's middle half▼ 2.1pp79.8%above the sector's middle half▲ 3.3pp73.2%above the sector's middle half▼ 6.6pp75.2%above the sector's middle half▲ 2.0pp71.8%above the sector's middle half▼ 3.4pp75.3%above the sector's middle half▲ 3.5pp
Current ratio6.26-7.88▲ 1.626.28above the sector's middle half▼ 1.597.28above the sector's middle half▲ 1.004.27above the sector's middle half▼ 3.014.54above the sector's middle half▲ 0.263.73above the sector's middle half▼ 0.804.14above the sector's middle half▲ 0.41
Return on assets (ROA)-1.1%-0.8%▲ 1.9pp-3.2%below the sector's middle half▼ 4.0pp6.4%within the sector's middle half▲ 9.5pp10.5%above the sector's middle half▲ 4.2pp9.4%within the sector's middle half▼ 1.1pp4.5%within the sector's middle half▼ 4.9pp5.0%within the sector's middle half▲ 0.5pp
Staff (FTE)2.2-2.2=0below the sector's middle half▼ 100%1.8below the sector's middle half2.2below the sector's middle half▲ 22.2%2.2below the sector's middle half=2.1below the sector's middle half▼ 4.5%2.1within the sector's middle half=
above within below the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €707,554
Fixed assets €19,111 ▼ 30.1%
Current assets €688,443 ▼ 8.1%
Equity and liabilities €707,554
Equity €532,755 ▼ 4.4%
Debt €174,799 ▼ 20.3%
Debt's share of the balance-sheet total falls from 28.2% to 24.7%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€53,176▼
2024 · €58,250
Cash flow
€45,311▼
2024 · €49,026
Quick ratio
3.12▲
2024 · 2.89
Debt to equity
0.33▼
2024 · 0.39
ROE
6.6%▲
2024 · 6.2%
Interest coverage
7.21▼
2024 · 7.60
Debt ≤ 1 year
€166,184▼
2024 · €200,850
Debt > 1 year
€8,584▼
2024 · €18,538
Income taxes
€502▼
2024 · €2,032
Staff costs
€160,338▲
2024 · €158,385
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 10,905 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 95.1% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet
0.7% went bankrupt
4.0% stopped otherwise
95.1% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 10,905 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 56 lines
Balance sheet Code20242025
Assets
Total assets20/58€776,847€707,554▼
Fixed assets21/28€27,326€19,111▼
Tangible fixed assets22/27€26,395€18,180▼
Plant, machinery and equipment23€3,630€2,154▼
Furniture and vehicles24€12,024€9,060▼
Other tangible fixed assets26€10,741€6,966▼
Financial fixed assets28€931€931=
Current assets29/58€749,521€688,443▼
Stocks and contracts in progress3€169,456€169,317▼
Stocks30/36€169,456€169,317▼
Amounts receivable within one year40/41€267,439€304,700▲
Trade receivables40€109,005€116,817▲
Other amounts receivable41€158,434€187,883▲
Current investments50/53€144,130€124,130▼
Cash at bank and in hand54/58€159,032€86,322▼
Deferred charges and accrued income490/1€9,463€3,974▼
Equity and liabilities
Total equity and liabilities10/49€776,847€707,554▼
Equity10/15€557,459€532,755▼
Contributions10/11€162,710€162,710=
Reserves13€168,628€158,628▼
Distributable reserves133€168,628€158,628▼
Profit (loss) carried forward14€226,121€211,417▼
Amounts payable17/49€219,388€174,799▼
Amounts payable after more than one year17€18,538€8,584▼
Financial debts170/4€18,538€8,584▼
Amounts payable within one year42/48€200,850€166,184▼
Current portion of amounts payable after more than one year42€9,587€9,953▲
Trade debts44€101,778€68,385▼
Suppliers440/4€101,778€68,385▼
Taxes, remuneration and social security45€38,346€27,846▼
Taxes450/3€14,704€2,005▼
Remuneration and social security454/9€23,641€25,841▲
Other amounts payable47/48€51,139€60,000▲
Accrued charges and deferred income492/3€0€30▲
Income statement Code20242025
Remuneration, social security and pensions62€158,385€160,338▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14,290€10,015▼
Other operating charges640/8€2,875€3,064▲
Gross operating margin9900€219,510€216,577▼
Operating profit (loss)9901€43,960€43,161▼
Financial income75/76B€471€10▼
Recurring financial income75€471€10▼
Financial charges65/66B€7,663€7,373▼
Recurring financial charges65€7,663€7,373▼
Profit (loss) for the period before taxes9903€36,768€35,798▼
Income taxes67/77€2,032€502▼
Profit (loss) for the period9904€34,736€35,296▲
Profit (loss) for the period to be appropriated9905€34,736€35,296▲
Appropriation of the result
Profit (loss) to be appropriated9906€276,121€261,417▼
Profit (loss) brought forward from the previous period14P€241,385€226,121▼
Transfer from equity791/2-€10,000
Transfer to equity691/2€0-
To other reserves6921€0-
Profit to be distributed694/7€50,000€60,000▲
Return on contributions (dividend)694-€10,000
Directors or managers695€50,000€50,000=
Social balance sheet
Average headcount (FTE)90872.12.1=

The notes to these accounts (19 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Non-recurring operating income76A----€7,537€0---
Remuneration, social security and pensions62---€79,438€102,719€87,847€158,385€160,338▲ 1.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€37,465€33,956€22,630€23,053€11,581€13,211€14,290€10,015▼ 29.9%
Other operating charges640/8---€1,924€1,942€4,620€2,875€3,064▲ 6.6%
Gross operating margin9900€144,245€145,308€113,125€169,298€215,718€193,245€219,510€216,577▼ 1.3%
Operating profit (loss)9901€1,218€17,529-€2,898€64,882€99,477€87,568€43,960€43,161▼ 1.8%
Financial income75/76B------€471€10▼ 97.9%
Recurring financial income75------€471€10▼ 97.9%
Financial charges65/66B---€6,867€7,348€7,680€7,663€7,373▼ 3.8%
Recurring financial charges65€7,681€9,158€16,945€6,867€7,348€7,680€7,663€7,373▼ 3.8%
Profit (loss) for the period before taxes9903-€6,463€8,372-€19,843€58,015€92,129€79,888€36,768€35,798▼ 2.6%
Income taxes67/77€476€3,180-€1€16,372€12,917€8,452€2,032€502▼ 75.3%
Profit (loss) for the period9904-€6,940€5,192-€19,842€41,643€79,212€71,437€34,736€35,296▲ 1.6%
Profit (loss) for the period to be appropriated9905-€6,940€5,192-€19,842€41,643€79,212€71,437€34,736€35,296▲ 1.6%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€656,170€636,403€627,756€654,302€752,829€761,631€776,847€707,554▼ 8.9%
Fixed assets21/28€92,924€62,368€46,465€28,413€51,185€32,631€27,326€19,111▼ 30.1%
Tangible fixed assets22/27€92,493€61,937€46,034€27,982€50,254€31,700€26,395€18,180▼ 31.1%
Plant, machinery and equipment23---€4,054€6,581€5,105€3,630€2,154▼ 40.7%
Furniture and vehicles24---€5,160€20,900€16,718€12,024€9,060▼ 24.7%
Other tangible fixed assets26---€18,768€22,774€9,877€10,741€6,966▼ 35.1%
Financial fixed assets28€431€431€431€431€931€931€931€931=
Current assets29/58€563,245€574,036€581,291€625,889€701,644€729,000€749,521€688,443▼ 8.1%
Stocks and contracts in progress3€157,419€161,508€160,589€159,020€160,250€164,787€169,456€169,317▼ 0.1%
Stocks30/36---€159,020€160,250€164,787€169,456€169,317▼ 0.1%
Amounts receivable within one year40/41€152,842€143,792€181,226€182,282€203,222€323,031€267,439€304,700▲ 13.9%
Trade receivables40---€82,147€90,766€177,392€109,005€116,817▲ 7.2%
Other amounts receivable41---€100,135€112,457€145,639€158,434€187,883▲ 18.6%
Current investments50/53€154,130€154,130€154,130€154,130€194,130€194,130€144,130€124,130▼ 13.9%
Cash at bank and in hand54/58€89,978€106,244€78,231€126,912€140,266€39,988€159,032€86,322▼ 45.7%
Deferred charges and accrued income490/1---€3,545€3,776€7,063€9,463€3,974▼ 58.0%
Equity and liabilities
Total equity and liabilities10/49€656,170€636,403€627,756€654,302€752,829€761,631€776,847€707,554▼ 8.9%
Equity10/15€495,083€500,274€480,432€522,075€551,287€572,723€557,459€532,755▼ 4.4%
Contributions10/11€162,710€162,710-€162,710€162,710€162,710€162,710€162,710=
Reserves13€71,145€76,337€76,337€117,980€147,192€168,628€168,628€158,628▼ 5.9%
Non-distributable reserves130/1---€16,891€16,891€0---
Reserves not available under the articles1311---€16,891€16,891€0---
Distributable reserves133---€101,089€130,301€168,628€168,628€158,628▼ 5.9%
Profit (loss) carried forward14€261,227€261,227€241,385€241,385€241,385€241,385€226,121€211,417▼ 6.5%
Amounts payable17/49€161,087€136,129€147,324€132,227€201,542€188,907€219,388€174,799▼ 20.3%
Amounts payable after more than one year17€71,010€63,065€54,815€46,250€37,357€28,124€18,538€8,584▼ 53.7%
Financial debts170/4---€46,250€37,357€28,124€18,538€8,584▼ 53.7%
Amounts payable within one year42/48€89,928€72,861€92,499€85,950€164,168€160,744€200,850€166,184▼ 17.3%
Current portion of amounts payable after more than one year42---€8,565€8,893€9,233€9,587€9,953▲ 3.8%
Trade debts44€60,540€42,866€65,726€45,983€68,457€62,375€101,778€68,385▼ 32.8%
Suppliers440/4---€45,983€68,457€62,375€101,778€68,385▼ 32.8%
Taxes, remuneration and social security45---€29,911€36,800€38,292€38,346€27,846▼ 27.4%
Taxes450/3---€19,407€20,743€26,113€14,704€2,005▼ 86.4%
Remuneration and social security454/9---€10,504€16,057€12,178€23,641€25,841▲ 9.3%
Other amounts payable47/48---€1,491€50,017€50,845€51,139€60,000▲ 17.3%
Accrued charges and deferred income492/3---€27€17€39€0€30-
Line20182019202020212022202320242025Change
Profit (loss) for the period9904-€6,940€5,192-€19,842€41,643€79,212€71,437€34,736€35,296▲ 1.6%
+ Depreciation and write-downs630€37,465€33,956€22,630€23,053€11,581€13,211€14,290€10,015▼ 29.9%
Operating cash flow (approximation)€30,525€39,148€2,788€64,696€90,793€84,648€49,026€45,311▼ 7.6%
Investment in fixed assets (approximation)--€3,400-€6,728-€5,001-€34,353€5,343-€8,985-€1,800▲ 80.0%
Change in cash-€16,266-€28,013€48,681€13,354-€100,277€119,044-€72,710-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 17 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 abbreviated format 24-07-2026 2026-00374794
31-12-2024 full format 16-07-2025 2025-00276564
31-12-2023 full format 14-06-2024 2024-00134345
31-12-2022 full format 09-06-2023 2023-00120333
31-12-2021 full format 20-06-2022 2022-20081012
31-12-2020 full format 17-06-2021 2021-21200158
31-12-2019 full format 15-06-2020 2020-17000358
31-12-2018 full format 26-06-2019 2019-23400203
31-12-2017 full format 18-06-2018 2018-20100027
31-12-2016 full format 10-07-2017 2017-30300566

Show all 17 filings

Similar companies · same sector, comparable size

Of the 5,202 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,874. 3,335 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
under verification, last change in 2024
This board is reconstructed from a single act (24361280). A Gazette act generally publishes only CHANGES, not a full roll call, so directors unchanged since then may be missing here. The KBO register holds the complete list of function holders.
Antoinette LOISE
Statutory director · since 15-02-2024
Current
ISAAC Brigitte
Administratrice statutaire · since 15-02-2024
Current
LOISE Jean-Luc
Statutory director · since 15-02-2024
Current
Pierre-Louis LOISE
Statutory director · since 15-02-2024
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
2 of this company's 3 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.

Mandate history

4 people since 2024, 4 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Antoinette LOISE
  • Manager, until 15-02-2024
  • Statutory director, from 15-02-2024 to date
ISAAC Brigitte
  • Administratrice statutaire, from 15-02-2024 to date
LOISE Jean-Luc
  • Statutory director, from 15-02-2024 to date
Pierre-Louis LOISE
  • Manager, until 15-02-2024
  • Statutory director, from 15-02-2024 to date
See the board, name and registered office on a given date →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

Group and network

Connections & network

4 current directors
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

On 24 June 2008, PROXYPHARMA LLB was incorporated.1 Total assets went from €656,170 in 2018 to €707,554 in 2025 and headcount from 2.2 to 2.1 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
24-07
NBB filing Annual accounts filed
financial year 2025 · abbreviated format
2025
16-07
NBB filing Annual accounts filed
financial year 2024 · full format
2024
14-06
NBB filing Annual accounts filed
financial year 2023 · full format
15-02
Gazette deed Appointments: LOISE Jean-Luc, ISAAC Brigitte and 2 others
Permanent representative: LOISE Jean-Luc · Resignations: Pierre-Louis LOISE (manager) and Antoinette LOISE (manager) · Amendment of the articles15 facts ▸
  • General meeting, 18-12-2023
  • Other provision, “constitution sous autre dénomination”, 24-06-2008 (deed in French)
  • Amendment of the articles (2 times)
  • Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
  • Reserve release, “supprimer le compte de capitaux propres statutairement indisponible créé en application de l’article 39,§2,deuxième alinéa, rendre ces fonds disponibles pour di…” (deed in French)
  • Capital
  • Director appointment, LOISE Jean-Luc (statutory director)
  • Director appointment, ISAAC Brigitte (administratrice statutaire)
  • Permanent representative, LOISE Jean-Luc
  • Director resignation, Pierre-Louis LOISE (manager)
  • Director resignation, Antoinette LOISE (manager)
  • Director appointment, Pierre-Louis LOISE (statutory director)
  • +3 further facts in this act
2023
09-06
NBB filing Annual accounts filed
financial year 2022 · full format
2022
31-12
Financial Highest result from 2018 to 2025net €79,212 ▲90.2%
Operating result €99,477, net result €79,212, both a record.
20-06
NBB filing Annual accounts filed
financial year 2021 · full format
2021
31-12
Financial Back to profitnet €41,643
Net result €41,643 after one loss-making year.
31-12
Financial Equity above €500,000equity €522,075 ▲8.7%
Equity rises from €480,432 to €522,075.
17-06
NBB filing Annual accounts filed
financial year 2020 · full format
2020
31-12
Financial Weakest financial yearnet -€19,842
Net result drops to -€19,842, the lowest in the series; recovery starts the following year.
15-06
NBB filing Annual accounts filed
financial year 2019 · full format
Show earlier events
2019
31-12
Financial Back to profitnet €5,192
Net result €5,192 after one loss-making year.
31-12
Financial Equity above €500,000equity €500,274 ▲1%
Equity rises from €495,083 to €500,274.
26-06
NBB filing Annual accounts filed
financial year 2018 · full format
2018
18-06
NBB filing Annual accounts filed
financial year 2017 · full format
2017
10-07
NBB filing Annual accounts filed
financial year 2016 · full format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 17 annual accounts filed, the latest 10 are here; all 17 are under Financials.
1 of 3 deeds read
About the unread acts

Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded24-06-2008
Financial year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
E-invoicing
Reachable via Peppol
Peppol ID 0208:0898752807
Also 0208:898752807
Also 9925:BE0898752807
Registered 19-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 22 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Food safety, FASFC

1 site
La Bruyèreunit no. 2.171.942.737
1 permission
Apotheek (LM>3 maand) · since 25-04-2024

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, La Bruyère · 1 establishment unit since 2008
registered office establishment The establishment unit on the map
Ground area
2,248 m²
Building footprint
544 m²
2 parcels, Wallonia. Linked by address, not a title deed.
1 establishment unit
PROXYPHARMA LLB
Rue du Chainia, Meux 79, 5081 La BruyèreRetail sale of pharmaceutical products
since 2008unit no. 2.171.942.737
2 parcels
Wallonia 2 (100%)
Cadastral parcel Region Area Buildings Height / floors
92088A0287/00X000 Wallonia 1,315 m² 1 · 167 m² -
92088A0135/00X000 Wallonia 933 m² 1 · 377 m² -
How the parcels are linked
Good to know
Both parcels match the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“Toutes opérations généralement quelconques se rapportant directement ou indirectement aux activités d’exploitation d’officines…” (deed in French)
9 activities (deed in French)
  1. Toutes opérations généralement quelconques se rapportant directement ou indirectement aux activités d’exploitation d’officines pharmaceutiques,homéopathiques et de bandagisteries,ainsi que la fabrication et la commercialisation de produits pharmaceutiques,homéopathiques et cosmétologiques
  2. À titre patrimonial,constituer,développer,promouvoir et gérer un patrimoine immobilier,et réaliser toute opération immobilière et foncière quelconque;hypothéquer ses immeubles et mettre en gage tous ses autres biens y compris son fonds de commerce
  3. En fonction de ses intérêts propres,se porter caution et donner toute sûreté personnelle ou réelle,ou accorder son aval pour tous prêts ou engagements quelconques tant pour elle-même que pour tous tiers,y compris les gérants,les associés,le personnel et les préposés de la société
  4. Contribution à l'établissement et au développement d'entreprises et en particulier de dispenser des avis techniques,commerciaux ou administratifs dans le sens le plus large du terme,à l'exception des conseils de placement d'argent et autres,fournir des conseils,son assistance et exécuter des services directement ou indirectement sur le plan de l'administration et des finances,de la vente,de la production,des techniques d’organisation et de distributions commerciales,et plus généralement de la gestion en général et de l’exercice de toutes activités de services et de management au sens le plus large de ces termes à toutes personnes physiques ou morales quelconques;exécuter tous mandats sous forme d'études d'organisation,d'expertises,d'actes et de conseils techniques ou autres dans tout domaine rentrant dans son objet social
  5. Constituer,développer et gérer un patrimoine mobilier et faire toutes opérations mobilières quelconques y compris celles se rapportant à tous droits mobiliers comme l'acquisition par voie d'inscription ou de cession et la gestion d'actions,de parts sociales,d'obligations convertibles ou non,de prêts de consommation,de prêts ordinaires,de bons de caisse ou autres valeurs mobilières,de quelque forme que ce soit,tant de personnes morales que d'entreprises,belges ou étrangères,existantes ou encore à constituer
  6. Exercer tout mandat généralement quelconque ainsi que toute fonction autorisée dans toute personne morale belge ou étrangère en ce compris la fonction d’administrateur,de délégué à la gestion journalière,de gérant et de liquidateur;rémunéré ou gratuit
  7. Consentir tous prêts ou garantir tous prêts consentis par des tiers,étant entendu que la société n'effectuera aucune activité soumise à des dispositions légales ou réglementaires applicables aux établissements de crédits et/ou financiers
  8. Accomplir toutes opérations commerciales,industrielles,financières,mobilières ou immobilières,soit pour son compte,soit pour le compte de tiers,se rapportant directement ou indirectement à son objet social ou de nature à en faciliter directement ou indirectement,entièrement ou partiellement la réalisation
  9. Exercer toutes fonctions et mandats et s’intéresser par voie d’apport,de fusion,de souscription ou de toute autre manière dans toutes autres affaires,entreprises,associations ou sociétés ayant un objet identique,analogue ou connexe au sien ou de nature à favoriser le développement de son entreprise,à lui procurer des ressources ou à faciliter l’écoulement des services et produits

The full purpose is in the deed

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
PROXYPHARMA LLB
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Région wallonne, par simple décision de l’organe d’administration,établir ou supprimer des sièges d’exploitation,pour autant que sans…” (deed in French)

deed of 15-02-2024

Who represents it, and how

Board ruleHow the board is made up, meets and takes decisions.
“Avec ou sans limitation de durée, un ou plusieurs administrateurs” (deed in French)
“Toute autre modification administrateur par assemblée générale comme modifications statuts, assemblée générale comme modifications statuts” (deed in French)
“Fixe ou proportionnelle, frais généraux plus représentation voyages déplacements” (deed in French)

deed of 15-02-2024

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
One provision in the deed
Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
“Moitié cédant moitié acquéreurs au prorata si plusieurs, prix notification initiale ou expert en cas contestation” (deed in French)
Share issue ruleHow and by whom new shares can be issued.
“Apport en numéraire avec émission de nouvelles actions – droit de préférence, l’organe qui procède à l’émission” (deed in French)

deed of 15-02-2024

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Second Friday of June at 18:00

deed of 15-02-2024

Oversight and winding up

Dissolution ruleWhen and by whom the company can be dissolved.
“Prévues pour modifications aux statuts, en tout temps” (deed in French)
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Dissolution pour quelque cause et à quelque moment, faculté désigner un ou plusieurs liquidateurs et déterminer pouvoirs et émoluments” (deed in French)

deed of 15-02-2024

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Éventuels versements futurs de la part non encore libérée à ce jour du capital souscrit dans le passé inscrit sur un compte de capitaux…” (deed in French)
Other provision: “Seul ou conjointement fixé par organe, gestion journalière” (deed in French)
Other provision: “Un ou plusieurs commissaires, contrôle de la société” (deed in French)
Other provision: “Séances procès-verbaux assemblée générale, liste présences,rapports,procurations,votes par correspondance” (deed in French)
Other provision: “Chaque action une voix,sous réserve actions sans droit de vote, délibérations assemblée générale” (deed in French)
Other provision: “Répartition bénéfice net réserves, assemblée générale sur proposition organe d'administration” (deed in French)
Other provision: “Article 5:141 CSA, paiement dividendes et acomptes” (deed in French)
Liquidation distribution: “Apurement dettes,charges,frais ou consignation montants nécessaires, actif net entre actionnaires en proportion actions,biens conservés…” (deed in French)
Other provision: “Communications,sommations,assignations,significations valablement faites, élection de domicile” (deed in French)
Other provision: “Compétence judiciaire, entre société,actionnaires,administrateurs,commissaires,liquidateurs relatifs affaires société et exécution statuts” (deed in French)
Other provision: “Droit commun, dispositions Code des sociétés et des associations auxquelles il ne serait pas licitement dérogé réputées inscrites” (deed in French)
4 more provisions in the deed, see the deed of 15-02-2024

deed of 15-02-2024